Drug development: Raise standards for preclinical cancer research

Drug development: Raise standards for preclinical cancer research. Begley, C. G. & Ellis, L. M. Nature, 483(7391):531–533, March, 2012.

Paper doi abstract bibtex

C. Glenn Begley and Lee M. Ellis propose how methods, publications and incentives must change if patients are to benefit.

@article{begley_drug_2012,
	title = {Drug development: {Raise} standards for preclinical cancer research},
	volume = {483},
	copyright = {© 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.},
	issn = {0028-0836},
	shorttitle = {Drug development},
	url = {http://www.nature.com/nature/journal/v483/n7391/full/483531a.html#t1},
	doi = {10.1038/483531a},
	abstract = {C. Glenn Begley and Lee M. Ellis propose how methods, publications and incentives must change if patients are to benefit.},
	language = {en},
	number = {7391},
	urldate = {2014-08-15},
	journal = {Nature},
	author = {Begley, C. Glenn and Ellis, Lee M.},
	month = mar,
	year = {2012},
	keywords = {Publishing, cancer, drug discovery},
	pages = {531--533},
}

Downloads: 0

{"_id":"GRMFjT9YWevi68BeX","bibbaseid":"begley-ellis-drugdevelopmentraisestandardsforpreclinicalcancerresearch-2012","author_short":["Begley, C. G.","Ellis, L. M."],"bibdata":{"bibtype":"article","type":"article","title":"Drug development: Raise standards for preclinical cancer research","volume":"483","copyright":"© 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.","issn":"0028-0836","shorttitle":"Drug development","url":"http://www.nature.com/nature/journal/v483/n7391/full/483531a.html#t1","doi":"10.1038/483531a","abstract":"C. Glenn Begley and Lee M. Ellis propose how methods, publications and incentives must change if patients are to benefit.","language":"en","number":"7391","urldate":"2014-08-15","journal":"Nature","author":[{"propositions":[],"lastnames":["Begley"],"firstnames":["C.","Glenn"],"suffixes":[]},{"propositions":[],"lastnames":["Ellis"],"firstnames":["Lee","M."],"suffixes":[]}],"month":"March","year":"2012","keywords":"Publishing, cancer, drug discovery","pages":"531–533","bibtex":"@article{begley_drug_2012,\n\ttitle = {Drug development: {Raise} standards for preclinical cancer research},\n\tvolume = {483},\n\tcopyright = {© 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.},\n\tissn = {0028-0836},\n\tshorttitle = {Drug development},\n\turl = {http://www.nature.com/nature/journal/v483/n7391/full/483531a.html#t1},\n\tdoi = {10.1038/483531a},\n\tabstract = {C. Glenn Begley and Lee M. Ellis propose how methods, publications and incentives must change if patients are to benefit.},\n\tlanguage = {en},\n\tnumber = {7391},\n\turldate = {2014-08-15},\n\tjournal = {Nature},\n\tauthor = {Begley, C. Glenn and Ellis, Lee M.},\n\tmonth = mar,\n\tyear = {2012},\n\tkeywords = {Publishing, cancer, drug discovery},\n\tpages = {531--533},\n}\n\n\n\n\n\n\n\n","author_short":["Begley, C. G.","Ellis, L. M."],"key":"begley_drug_2012","id":"begley_drug_2012","bibbaseid":"begley-ellis-drugdevelopmentraisestandardsforpreclinicalcancerresearch-2012","role":"author","urls":{"Paper":"http://www.nature.com/nature/journal/v483/n7391/full/483531a.html#t1"},"keyword":["Publishing","cancer","drug discovery"],"metadata":{"authorlinks":{}},"downloads":0,"html":""},"bibtype":"article","biburl":"https://bibbase.org/zotero/lconcha","dataSources":["vCGHbq7YMoL4xbgTv"],"keywords":["publishing","cancer","drug discovery"],"search_terms":["drug","development","raise","standards","preclinical","cancer","research","begley","ellis"],"title":"Drug development: Raise standards for preclinical cancer research","year":2012}